Sipuleucel-T is a vaccine made from patient-isolated dendritic cells with known prostate tumor-associated antigens and targets explicitly prostatic acid phosphatase (PAP) (Li et al., 2021). The gene discussed is ACP3; the disease is prostate neoplasm.